Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Stroke. 2017 Aug 2;48(9):2511–2518. doi: 10.1161/STROKEAHA.117.016976

Table 1.

Description of sites overall, sites approved for randomization (“green-lighted”) and sites that have randomized (n and (%) of sites).

All Approved for Randomization Randomized 1 or more patients
Number of Sites 147 122 89
PI Specialty Interventional Radiology/Neuroradiology 6 (4%) 6 (5%) 4 (4%)
Neurology 43 (29%) 33 (27%) 21 (24%)
Neurosurgery 14 (10%) 8 (7%) 7 (8%)
Vascular Surgery 44 (30%) 40 (33%) 31 (35%)
Cardiology 40 (27%) 35 (29%) 26 (29%)
Site Type Private Hospital 50 (34%) 39 (32%) 24 (27%)
Private office 18 (12%) 17 (14%) 16 (18%)
VA Medical Center 8 (5%) 7 (6%) 6 (7%)
Academic 71 (48%) 59 (48%) 43 (48%)
Affiliates Yes 45 (31%) 33 (27%) 22 (25%)
No 102 (69%) 89 (73%) 67 (75%)
StrokeNET Membership StrokeNET 57 (39%) 46 (38%) 33 (37%)
Non-StrokeNET 90 (61%) 75 (62%) 56 (63%)
CIRB Yes 75 (51%) 62 (51%) 46 (52%)
No 72 (49%) 60 (49%) 43 (48%)
Team Complement Full 123 (84%) 105 (86%) 77 (87%)
Partial 24 (16%) 17 (14%) 12 (13%)
Annual number of CEA <10 10 (7%) 8 (7%) 7 (8%)
10–25 14 (10%) 11 (9%) 5 (6%)
26–50 35 (24%) 30 (25%) 20 (22%)
>50 88 (60%) 73 (60%) 57 (64%)
Annual number of CAS <10 29 (20%) 23 (19%) 15 (17%)
10–25 48 (33%) 40 (33%) 31 (35%)
26–50 41 (28%) 35 (29%) 26 (29%)
>50 29 (20%) 24 (20%) 17 (19%)
Study approval by the site selection committee CAS only 8 (5%) 5 (4%) 5 (6%)
CEA only 11 (7%) 8 (7%) 4 (4%)
Both 128 (87%) 109 (89%) 80 (90%)
Study participation to randomize Neither 25 (17%) 0 (0%) 0 (0%)
CAS only 9 (6%) 9 (7%) 7 (8%)
CEA only 39 (27%) 39 (32%) 19 (21%)
Both 74 (50%) 74 (61%) 63 (71%)
Participation in CREST Top Half 36 (24%) 35 (29%) 29 (33%)
Bottom Half 35 (24%) 29 (24%) 22 (24%)
Not in CREST 76 (52%) 58 (48%) 39 (44%)